Mark Hillman Hillman Capital Management
Mark Hillman is associated with Hillman Capital Management, a firm focused on fundamental equity research and long-term portfolio management. The firm’s public filings are followed by investors interested in actively managed, research-driven U.S. equity exposure. Hillman’s process emphasizes business analysis and valuation discipline rather than short-term trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Estee Lauder
EL
|
+$5.84M |
| 2 |
Pfizer
PFE
|
+$5.68M |
| 3 |
CarMax
KMX
|
+$5.07M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.36M |
| 5 |
JWN
Nordstrom
JWN
|
+$1.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$7.75M |
| 2 |
Microsoft
MSFT
|
+$2.56M |
| 3 |
Intel
INTC
|
+$2.09M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.82M |
| 5 |
Walt Disney
DIS
|
+$1.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.15% |
| 2 | Technology | 17.75% |
| 3 | Communication Services | 13.84% |
| 4 | Consumer Staples | 12.6% |
| 5 | Financials | 11.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Simon Property Group
SPG
$70.6B
| $10.1M | 3.49% |
70,956
+53
| +0.1% | +$6.41K |
|
|
2
Microsoft
MSFT
$3.59T
| $9.72M | 3.36% |
25,856
-7,196
| -22% | -$2.56M |
|
3
ASML
ASML
$677B
| $9.44M | 3.26% |
12,475
-5
| -0% | -$3.3K |
|
4
Boeing
BA
$169B
| $9.28M | 3.2% |
35,592
-7,051
| -17% | -$1.51M |
|
|
5
Intel
INTC
$476B
| $9.24M | 3.19% |
183,949
-51,556
| -22% | -$2.09M |
|
6
Wells Fargo
WFC
$254B
| $9.16M | 3.16% |
186,151
-25,085
| -12% | -$1.08M |
|
7
CVS Health
CVS
$119B
| $8.97M | 3.1% |
113,662
+1,354
| +1% | +$96.4K |
|
8
Amazon
AMZN
$2.79T
| $8.95M | 3.09% |
58,891
-866
| -1% | -$121K |
|
9
International Flavors & Fragrances
IFF
$21.5B
| $8.93M | 3.08% |
110,277
-15,000
| -12% | -$1.08M |
|
10
Biogen
BIIB
$32B
| $8.92M | 3.08% |
34,476
+170
| +0.5% | +$41.8K |
|
11
Kraft Heinz
KHC
$30.3B
| $8.69M | 3% |
235,042
+504
| +0.2% | +$17.1K |
|
12
GSK
GSK
$105B
| $8.65M | 2.99% |
233,386
+522
| +0.2% | +$18.7K |
|
13
DuPont de Nemours
DD
$18.7B
| $8.56M | 2.96% |
88,653
-17
| -0% | -$1.55K |
|
14
TSMC
TSM
$2.17T
| $8.43M | 2.91% |
81,015
-15,007
| -16% | -$1.43M |
|
15
Baxter International
BAX
$13.6B
| $8.36M | 2.89% |
216,268
-2,980
| -1% | -$105K |
|
16
AT&T
T
$173B
| $8.12M | 2.8% |
483,663
-26,948
| -5% | -$425K |
|
17
AB InBev
BUD
$155B
| $7.96M | 2.75% |
123,114
-26,185
| -18% | -$1.55M |
|
18
Warner Bros
WBD
$71.6B
| $7.71M | 2.66% |
677,683
-30,360
| -4% | -$328K |
|
|
K
19
DELISTED
Kellanova
K
| $7.62M | 2.63% |
136,202
+13,132
| +11% | +$686K |
|
|
JWN
20
DELISTED
Nordstrom
JWN
| $7.29M | 2.52% |
395,139
+94,884
| +32% | +$1.46M |
|
21
Salesforce
CRM
$171B
| $7.15M | 2.47% |
27,171
-44
| -0.2% | -$9.96K |
|
22
Lam Research
LRCX
$393B
| $7.1M | 2.45% |
90,630
-220
| -0.2% | -$15K |
|
|
BNY
23
Bank of New York Mellon
BNY
$108B
| $7.1M | 2.45% |
136,358
| – | – |
|
24
US Bancorp
USB
$96.7B
| $6.75M | 2.33% |
156,000
| – | – |
|
25
Emerson Electric
EMR
$87.7B
| $6.71M | 2.32% |
68,983
| – | – |
|
Similar funds
Mark Hillman's Q4 2023 Portfolio in Review
As of Q4 2023, Mark Hillman held 56 positions worth $290M, up 12% from $260M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Mark Hillman's Q4 2023 filing shows 3 new, 12 increased, 28 reduced and 3 closed positions. Its largest new stake was Estee Lauder: 44,000 shares worth $6.43M. The largest sale was Adobe, an estimated $7.75M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Communication Services.
- Mark Hillman's largest Q4 2023 buy was Estee Lauder: 44,000 shares worth $6.43M.
- Mark Hillman added most to CarMax in Q4 2023, an estimated $5.07M increase.
- Mark Hillman's biggest Q4 2023 reduction was Microsoft, cutting an estimated $2.56M.
- Mark Hillman fully exited Adobe in Q4 2023, selling an estimated $7.75M.
- Mark Hillman's ten largest holdings make up 32% of its $290M portfolio in Q4 2023.
- Mark Hillman opened 3 new positions and closed 3 in Q4 2023.
- Mark Hillman's portfolio value rose 12% quarter-over-quarter to $290M.
Based on Hillman Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.